Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Breast Cancer Research and Treatment|November 12, 2010
Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinomaPaola Maroni, Emanuela Matteucci, Alessandro Luzzati, et al.
Carcinogenesis|March 24, 2017
In bone metastasis miR-34a-5p absence inversely correlates with Met expression, while Met oncogene is unaffected by miR-34a-5p in non-metastatic and metastatic breast carcinomasPaola Maroni, Rossella Puglisi, Gianfranco Mattia, et al.
Journal of Cellular Physiology|June 23, 2010
Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGFPaola Bendinelli, Emanuela Matteucci, Giada Dogliotti, et al.
Molecular and Cellular Endocrinology|May 9, 2002
Amino acid- and lipid-induced insulin resistance in rat heart: molecular mechanismsIleana Terruzzi, Sonia Allibardi, Paola Bendinelli, et al.
Tissue Barriers|December 7, 2023
Surface layer proteins from <i>Lactobacillus helveticus</i> ATCC® 15009™ affect the gut barrier morphology and functionPaola Bendinelli, Ivano De Noni, Stefano Cattaneo, et al.
International Journal of Molecular Sciences|December 26, 2015
High SPARC Expression Starting from Dysplasia, Associated with Breast Carcinoma, Is Predictive for Bone Metastasis without Enhancement of Plasma LevelsPaola Maroni, Paola Bendinelli, Daniele Morelli, et al.
Biochemical and Biophysical Research Communications|October 23, 2012
Chemical and genetic blockade of HDACs enhances osteogenic differentiation of human adipose tissue-derived stem cells by oppositely affecting osteogenic and adipogenic transcription factorsPaola Maroni, Anna Teresa Brini, Elena Arrigoni, et al.
Foods (Basel, Switzerland)|January 25, 2025
Ex Vivo, In Vitro and In Vivo Bone Health Properties of Grana Padano CheeseCristina Martelli, Luisa Ottobrini, Anita Ferraretto, et al.
Biotechnology Advances|August 30, 2011
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cellsGiovanni Vitale, Silvia Zappavigna, Monica Marra, et al.
Pageof 4